Arcus Biosciences (RCUS) Receivables - Other (2017 - 2025)
Historic Receivables - Other for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to $11.0 million.
- Arcus Biosciences' Receivables - Other fell 3125.0% to $11.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year decrease of 3125.0%. This contributed to the annual value of $20.0 million for FY2024, which is 4736.84% down from last year.
- According to the latest figures from Q3 2025, Arcus Biosciences' Receivables - Other is $11.0 million, which was down 3125.0% from $15.0 million recorded in Q2 2025.
- Over the past 5 years, Arcus Biosciences' Receivables - Other peaked at $52.0 million during Q3 2023, and registered a low of -$715.0 million during Q1 2022.
- In the last 5 years, Arcus Biosciences' Receivables - Other had a median value of $16.0 million in 2024 and averaged -$18.6 million.
- Over the last 5 years, Arcus Biosciences' Receivables - Other had its largest YoY gain of 217498.41% in 2022, and its largest YoY loss of 1375807.07% in 2022.
- Quarter analysis of 5 years shows Arcus Biosciences' Receivables - Other stood at $17.3 million in 2021, then dropped by 19.12% to $14.0 million in 2022, then skyrocketed by 171.16% to $38.0 million in 2023, then crashed by 47.37% to $20.0 million in 2024, then crashed by 45.0% to $11.0 million in 2025.
- Its Receivables - Other was $11.0 million in Q3 2025, compared to $15.0 million in Q2 2025 and $15.0 million in Q1 2025.